Literature DB >> 11055585

Chalcone, acyl hydrazide, and related amides kill cultured Trypanosoma brucei brucei.

L Troeberg1, X Chen, T M Flaherty, R E Morty, M Cheng, H Hua, C Springer, J H McKerrow, G L Kenyon, J D Lonsdale-Eccles, T H Coetzer, F E Cohen.   

Abstract

BACKGROUND: Protozoan parasites of the genus Trypanosoma cause disease in a wide range of mammalian hosts. Trypanosoma brucei brucei, transmitted by tsetse fly to cattle, causes a disease (Nagana) of great economic importance in parts of Africa. T. b. brucei also serves as a model for related Trypanosoma species, which cause human sleeping sickness.
MATERIALS AND METHODS: Chalcone and acyl hydrazide derivatives are known to retard the growth of Plasmodium falciparum in vitro and inhibit the malarial cysteine proteinase, falcipain. We tested the effects of these compounds on the growth of bloodstream forms of T. b. brucei in cell culture and in a murine trypanosomiasis model, and investigated their ability to inhibit trypanopain-Tb, the major cysteine proteinase of T. b. brucei.
RESULTS: Several related chalcones, acyl hydrazides, and amides killed cultured bloodstream forms of T. b. brucei, with the most effective compound reducing parasite numbers by 50% relative to control populations at a concentration of 240 nM. The most effective inhibitors protected mice from an otherwise lethal T. b. brucei infection in an in vivo model of acute parasite infection. Many of the compounds also inhibited trypanopain-Tb, with the most effective inhibitor having a Ki value of 27 nM. Ki values for trypanopain-Tb inhibition were up to 50- to 100-fold lower than for inhibition of mammalian cathepsin L, suggesting the possibility of selective inhibition of the parasite enzyme.
CONCLUSIONS: Chalcones, acyl hydrazides, and amides show promise as antitrypanosomal chemotherapeutic agents, with trypanopain-Tb possibly being one of their in vivo targets.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11055585      PMCID: PMC1949976     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  10 in total

1.  Trypanocidal and cytotoxic evaluation of synthesized thiosemicarbazones as potential drug leads against sleeping sickness.

Authors:  Bienvenu Glinma; Sika D S Kpoviessi; Fernand A Gbaguidi; Coco N Kapanda; Joanne Bero; Joëlle Quetin-Leclercq; Mansourou Moudachirou; Jacques Poupaert; Georges C Accrombessi; Emma W Gachomo; Lamine Baba-Moussa; Simeon O Kotchoni
Journal:  Mol Biol Rep       Date:  2014-01-10       Impact factor: 2.316

2.  (2E)-1-(3-Chloro-phen-yl)-3-(4-chloro-phen-yl)prop-2-en-1-one.

Authors:  Jerry P Jasinski; Ray J Butcher; B Narayana; K Veena; H S Yathirajan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-03

3.  (2E)-1-(3-Chloro-phen-yl)-3-phenyl-prop-2-en-1-one.

Authors:  Jerry P Jasinski; Ray J Butcher; B Narayana; K Veena; H S Yathirajan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-12-16

4.  (E)-1-(4-Bromo-phen-yl)-3-(2-meth-oxy-phen-yl)prop-2-en-1-one.

Authors:  Jerry P Jasinski; Albert E Pek; B Narayana; Prakash K Kamath; H S Yathirajan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-07-14

5.  (2E)-3-[4-(Dimethyl-amino)-phen-yl]-1-(4-fluoro-phen-yl)prop-2-en-1-one.

Authors:  Jerry P Jasinski; Ray J Butcher; B P Siddaraju; B Narayana; H S Yathirajan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-01-08

6.  (2E)-1-(2-Bromo-phen-yl)-3-(4-chloro-phen-yl)prop-2-en-1-one.

Authors:  Jerry P Jasinski; Ray J Butcher; K Veena; B Narayana; H S Yathirajan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-06-16

7.  (E)-3-(4-Hy-droxy-3-meth-oxy-phen-yl)-1-(4-hy-droxy-phen-yl)prop-2-en-1-one.

Authors:  S Sathya; D Reuben Jonathan; K Prathebha; G Usha; J Jovita
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-04-26

Review 8.  High Throughput and Computational Repurposing for Neglected Diseases.

Authors:  Helen W Hernandez; Melinda Soeung; Kimberley M Zorn; Norah Ashoura; Melina Mottin; Carolina Horta Andrade; Conor R Caffrey; Jair Lage de Siqueira-Neto; Sean Ekins
Journal:  Pharm Res       Date:  2018-12-17       Impact factor: 4.200

9.  Role of the Trypanosoma brucei natural cysteine peptidase inhibitor ICP in differentiation and virulence.

Authors:  Camila C Santos; Graham H Coombs; Ana Paula C A Lima; Jeremy C Mottram
Journal:  Mol Microbiol       Date:  2007-10-17       Impact factor: 3.501

10.  Identification of Chalcones as Fasciola hepatica Cathepsin L Inhibitors Using a Comprehensive Experimental and Computational Approach.

Authors:  Florencia Ferraro; Alicia Merlino; Nicolás Dell Oca; Jorge Gil; José F Tort; Mercedes Gonzalez; Hugo Cerecetto; Mauricio Cabrera; Ileana Corvo
Journal:  PLoS Negl Trop Dis       Date:  2016-07-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.